Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2020

Ausgabe 3/2020

Inhaltsverzeichnis ( 26 Artikel )

25.02.2020 | Review | Ausgabe 3/2020 Open Access

Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis

Noman Paracha, Adriana Reyes, Véronique Diéras, Ian Krop, Xavier Pivot, Ander Urruticoechea

17.02.2020 | Preclinical study | Ausgabe 3/2020

Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer

Thomas L. Gonzalez, Molly Hancock, Siqi Sun, Christina L. Gersch, Jose M. Larios, Wadie David, Jiantao Hu, Daniel F. Hayes, Shaomeng Wang, James M. Rae

16.03.2020 | Correction | Ausgabe 3/2020

Correction to: Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer

Thomas L. Gonzalez, Molly Hancock, Siqi Sun, Christina L. Gersch, Jose M. Larios, Wadie David, Jiantao Hu, Daniel F. Hayes, Shaomeng Wang, James M. Rae

02.03.2020 | Preclinical study | Ausgabe 3/2020

Anti-HER2 antibody therapy using gene-transduced adipocytes for HER2-positive breast cancer

Takahito Masuda, Hiroshi Fujimoto, Ryotaro Teranaka, Masayuki Kuroda, Yasuyuki Aoyagi, Takeshi Nagashima, Takafumi Sangai, Mamoru Takada, Ayako Nakagawa, Yoshitaka Kubota, Koutaro Yokote, Masayuki Ohtsuka

04.03.2020 | Preclinical study | Ausgabe 3/2020 Open Access

G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer

Kaitlyn J. Andreano, Suzanne E. Wardell, Jennifer G. Baker, Taylor K. Desautels, Robert Baldi, Christina A. Chao, Kendall A. Heetderks, Yeeun Bae, Rui Xiong, Debra A. Tonetti, Lauren M. Gutgesell, Jiong Zhao, Jessica A. Sorrentino, Delita A. Thompson, John E. Bisi, Jay C. Strum, Gregory R. J. Thatcher, John D. Norris

14.02.2020 | Clinical trial | Ausgabe 3/2020

Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy

Denise A. Yardley, Nancy Peacock, Brooke Daniel, Betrand Anz, David C. Molthrop Jr, Sonalee K. Shroff, Robyn Young, Aleksander Jankov, Amy Vander Woude, Mythili Shastry, Johanna Pasek, Laura M. DeBusk, John D. Hainsworth

19.02.2020 | Clinical Trial | Ausgabe 3/2020

Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients

Minsung Kim, Hanna Kim, Sei Hyun Ahn, Vafa Tabatabaie, Sung Wook Choi, Guiyun Sohn, Sae Byul Lee, Beom Seok Ko, Il Yong Chung, Jisun Kim, Jong Won Lee, Byung Ho Son, Hee Jeong Kim

25.02.2020 | Clinical Trial | Ausgabe 3/2020

The long-term effect of age on cardiovascular disease in patients with breast cancer who received chemotherapy

Ye Won Jeon, Hye Won Bang, Young Jin Suh, GeeHee Kim

02.03.2020 | Clinical trial | Ausgabe 3/2020 Open Access

Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial

Irene E. G. van Hellemond, Carolien H. Smorenburg, Petronella G. M. Peer, Astrid C. P. Swinkels, Caroline M. Seynaeve, Maurice J. C. van der Sangen, Judith R. Kroep, Hiltje de Graaf, Aafke H. Honkoop, Frans L. G. Erdkamp, Franchette W. P. J. van den Berkmortel, Wilfred K. de Roos, Sabine C. Linn, Alexander L. T. Imholz, Maaike de Boer, Vivianne C. G. Tjan-Heijnen, the Dutch Breast Cancer Research Group (BOOG)

05.03.2020 | Clinical trial | Ausgabe 3/2020

Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer

Madoka Iwase, Masashi Ando, Kenjiro Aogi, Tomoyuki Aruga, Kenichiro Inoue, Akihiko Shimomura, Eriko Tokunaga, Norikazu Masuda, Hideko Yamauchi, Toshinari Yamashita, Hiroji Iwata

11.03.2020 | Clinical trial | Ausgabe 3/2020

Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period

Ciara C. O’Sullivan, Sheeba Irshad, Zheyu Wang, Zhuojun Tang, Christopher Umbricht, Gary L. Rosner, Mindy S. Christianson, Vered Stearns, Karen Lisa Smith

12.03.2020 | Clinical trial | Ausgabe 3/2020

Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy

Theodore S. Jennaro, Fang Fang, Kelley M. Kidwell, Ellen M. Lavoie Smith, Kiran Vangipuram, Monika L. Burness, Jennifer J. Griggs, Catherine Van Poznak, Daniel F. Hayes, N. Lynn Henry, Daniel L. Hertz

13.03.2020 | Clinical trial | Ausgabe 3/2020 Open Access

A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer

Hiroshi Ishiguro, Norikazu Masuda, Nobuaki Sato, Kenji Higaki, Takashi Morimoto, Yasuhiro Yanagita, Makiko Mizutani, Shoichiro Ohtani, Koji Kaneko, Tomomi Fujisawa, Masato Takahashi, Takayuki Kadoya, Nobuki Matsunami, Yutaka Yamamoto, Shinji Ohno, Toshimi Takano, Satoshi Morita, Sachiko Tanaka-Mizuno, Masakazu Toi

16.03.2020 | Clinical trial | Ausgabe 3/2020 Open Access

De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study

J. M. Simons, L. B. Koppert, E. J. T. Luiten, C. C. van der Pol, S. Samiei, J. H. W. de Wilt, S. Siesling, M. L. Smidt

14.02.2020 | Epidemiology | Ausgabe 3/2020

Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancers

S. P. Corona, M. Bortul, S. Scomersi, C. Bigal, C. Bottin, F. Zanconati, S. B. Fox, F. Giudici, D. Generali

15.02.2020 | Epidemiology | Ausgabe 3/2020

The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women’s Health Initiative

Rachel Yung, Roberta M. Ray, Joshua Roth, Lisa Johnson, Greg Warnick, Garnet L. Anderson, Candyce H. Kroenke, Rowan T. Chlebowski, Michael S. Simon, Chunkit Fung, Kathy Pan, Di Wang, Wendy E. Barrington, Kerryn W. Reding

18.02.2020 | Epidemiology | Ausgabe 3/2020

The spectrum of BRCA1 and BRCA2 mutations and clinicopathological characteristics in Chinese women with early-onset breast cancer

Lili Chen, Fangmeng Fu, Meng Huang, Jinxing Lv, Wenzhe Zhang, Chuan Wang

19.02.2020 | Epidemiology | Ausgabe 3/2020

Trajectory of recurrent falls in post-menopausal breast cancer survivors and in matched cancer-free controls

Kathy Pan, Roberta M. Ray, Jane A. Cauley, Aladdin H. Shadyab, Arti Hurria, Rowan T. Chlebowski

21.02.2020 | Epidemiology | Ausgabe 3/2020

Adherence trajectories of adjuvant endocrine therapy in the five years after its initiation among women with non-metastatic breast cancer: a cohort study using administrative databases

Laurence Lambert-Côté, Anne-Déborah Bouhnik, Marc-Karim Bendiane, Cyril Bérenger, Myrto Mondor, Laetitia Huiart, Sophie Lauzier

22.02.2020 | Epidemiology | Ausgabe 3/2020

A cumulative index of exposure to endogenous estrogens and breast cancer by molecular subtypes in northern Mexican women

Elodia Rojas-Lima, Brenda Gamboa-Loira, Mariano E. Cebrián, Stephen J. Rothenberg, Lizbeth López-Carrillo

03.03.2020 | Epidemiology | Ausgabe 3/2020

Does persistent use of radiation in women > 70 years of age with early-stage breast cancer reflect tailored patient-centered care?

Lauren J. Taylor, Jennifer S. Steiman, Bethany Anderson, Jessica R. Schumacher, Lee G. Wilke, Caprice C. Greenberg, Heather B. Neuman

13.03.2020 | Epidemiology | Ausgabe 3/2020 Open Access

The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience

Valerie E. Crolley, Husam Marashi, Shabbir Rawther, Bhawna Sirohi, Marina Parton, Janine Graham, Anup Vinayan, Stephanie Sutherland, Anne Rigg, Anshu Wadhawan, Catherine Harper-Wynne, Emma Spurrell, Hannah Bond, Fharat Raja, Judy King

14.03.2020 | Epidemiology | Ausgabe 3/2020

Outcomes of primary endocrine therapy in elderly women with stage I–III breast cancer: a SEER database analysis

Cai Yuan, Zhigang Xie, Jiang Bian, Jinhai Huo, Karen Daily

11.03.2020 | Letter to the Editor | Ausgabe 3/2020

HER2-positivity in mucinous cancer might be related to accompanying infiltrating ductal carcinoma histology

Kadri Altundag

14.03.2020 | Letter to the Editor | Ausgabe 3/2020

Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer

Ge Ma, Bin Zhang, Jin Xu

16.03.2020 | Letter to the Editor | Ausgabe 3/2020

Uterine ultrasound and endometrial biopsy in tamoxifen users

P. Neven, W. Froyman, S. Timmerman, D. Timmerman

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise